TriSalus Life Sciences Ownership | Who Owns TriSalus Life Sciences?
TriSalus Life Sciences Ownership Summary
TriSalus Life Sciences is owned by 25.75% institutional investors, 40.56% insiders, and 33.69% retail investors. Nantahala capital management is the largest institutional shareholder, holding 6.08% of TLSI shares.
TLSI Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | TriSalus Life Sciences | 25.75% | 40.56% | 33.69% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Medical Device Stocks | 52.08% | 10.61% | 37.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Nantahala capital management | 2.00M | 6.08% | $10.90M |
Awm investment company | 1.25M | 3.80% | $6.81M |
Gilder gagnon howe | 1.09M | 3.32% | $5.96M |
Wealthcare advisory partners | 643.74K | 2.43% | $3.23M |
Blackrock funding, inc. /de | 621.69K | 1.89% | $3.39M |
Alyeska investment group | 557.50K | 1.69% | $3.04M |
Millennium management | 133.38K | 0.50% | $736.26K |
Msd partners | 40.00K | 0.12% | $218.00K |
Connective capital management | 32.80K | 0.10% | $178.74K |
State street | 20.20K | 0.08% | $101.20K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Awm investment company | 1.25M | 0.76% | $6.81M |
Nantahala capital management | 2.00M | 0.43% | $10.90M |
Connective capital management | 32.80K | 0.17% | $178.74K |
Msd partners | 40.00K | 0.13% | $218.00K |
Wealthcare advisory partners | 643.74K | 0.09% | $3.23M |
Gilder gagnon howe | 1.09M | 0.06% | $5.96M |
Alyeska investment group | 557.50K | 0.01% | $3.04M |
Connecticut wealth management | 22.30K | 0.01% | $121.55K |
Vestcor | 23.38K | 0.00% | $127.00K |
Hoertkorn richard charles | 668.00 | 0.00% | $3.64K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Nantahala capital management | 2.00M | 0.43% | 2.00M |
Awm investment company | 1.25M | 0.76% | 1.25M |
Blackrock funding, inc. /de | 621.69K | 0.00% | 591.42K |
Alyeska investment group | 557.50K | 0.01% | 557.50K |
Gilder gagnon howe | 1.09M | 0.06% | 265.62K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Duquesne family office | - | - | -426.92K |
Renaissance | - | - | -20.20K |
Virtu financial | - | - | -19.88K |
Walleye capital | - | - | -14.38K |
Magnetar financial | - | - | -14.23K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Nantahala capital management | 2.00M | 0.43% | 2.00M | $10.90M |
Awm investment company | 1.25M | 0.76% | 1.25M | $6.81M |
Alyeska investment group | 557.50K | 0.01% | 557.50K | $3.04M |
Sterling capital management | 339.00 | - | 339.00 | $1.85K |
Sold Out
Holder | Change |
---|---|
Coldstream capital management | -150.00 |
Tower research capital llc (trc) | -555.00 |
Wolverine asset management | -1.03K |
Exos asset management | -3.60K |
Prudential financial | -10.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 47 | 42.42% | 8,470,337 | 187.35% | 25 | 24.11% | 38 | 72.73% | 2 | 100.00% |
Mar 31, 2025 | 1 | -96.15% | 4,008 | -99.83% | - | 0.02% | 1 | -85.71% | - | -100.00% |
Dec 31, 2024 | 25 | -19.35% | 2,295,289 | 5.72% | 8 | 12.90% | 7 | -50.00% | 8 | -11.11% |
Sep 30, 2024 | 31 | 19.23% | 2,171,190 | 21.63% | 8 | 14.69% | 14 | 16.67% | 9 | - |
Jun 30, 2024 | 26 | 8.33% | 1,785,098 | 92.78% | 7 | 47.37% | 12 | -14.29% | 9 | 80.00% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 19, 2025 | Cox Bryan F. | Chief of Research | Sell | $24.68K |
May 19, 2025 | Devlin Jodi | Chief of Clinical Operations | Sell | $24.68K |
May 19, 2025 | Marshak Richard | Chief Commercial Officer | Sell | $34.17K |
May 19, 2025 | Stevens Jennifer | Chief Regulatory Officer | Sell | $45.09K |
Feb 05, 2025 | Young James Emmett | Chief Financial Officer | Buy | $33.90K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | - | 4 |
2025 Q1 | 8 | - |
2024 Q4 | 4 | 2 |
2024 Q3 | 4 | 1 |
TLSI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools